National Toxicology Program Scientific Advisory Committee on Alternative Toxicological Methods; Announcement of Meeting; Request for Comments, 45253-45254 [2013-17919]

Download as PDF Federal Register / Vol. 78, No. 144 / Friday, July 26, 2013 / Notices tkelley on DSK3SPTVN1PROD with NOTICES applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council on Drug Abuse. Date: September 4, 2013. Closed: 8:30 AM to 10:30 AM. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, Conference Rooms C & D, 6001 Executive Boulevard, Rockville, MD 20852. Open: 10:30 AM to 4:00 PM. Agenda: This portion of the meeting will be open to the public for announcements and reports of administrative, legislative and program developments in the drug abuse field. Place: National Institutes of Health, Neuroscience Center, Conference Rooms C & D, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: Mark Swieter, Ph.D., Acting Director, Office of Extramural Affairs, Branch Chief, Extramural Activities Branch, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, Room 4243, Bethesda, MD 20892–9550, (301) 435– 1389, ms80x@nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: www.drugabuse.gov/NACDA/ NACDAHome.html, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: July 19, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–17917 Filed 7–25–13; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 18:54 Jul 25, 2013 Jkt 229001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Toxicology Program Scientific Advisory Committee on Alternative Toxicological Methods; Announcement of Meeting; Request for Comments This notice announces a meeting of the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM). SACATM advises the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), the National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), and the Director of the National Institute of Environmental Health Sciences (NIEHS) and NTP regarding statutorily mandated duties of ICCVAM and activities of NICEATM. Information about the meeting and registration are available at https://ntp.niehs.nih.gov/go/32822. DATES: Meeting: September 24, 2013, beginning at 9:00 a.m. Eastern Daylight Time and continuing until adjournment at approximately 4:30 p.m. Written Public Comments Submissions: Deadline is September 10, 2013. Pre-registration for Meeting and/or Oral Comments: Deadline is September 17, 2013. ADDRESSES: Meeting Location: Rodbell Auditorium, Rall Building, NIEHS, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709. Meeting Web page: The preliminary agenda, registration, and other meeting materials are at https://ntp.niehs.nih.gov/ go/32822. It is not necessary to preregister for the meeting to view the webcast. Webcast: A link to access the meeting webcast will be available on the meeting Web page. FOR FURTHER INFORMATION CONTACT: Dr. Lori White, Designated Federal Officer for SACATM, Office of Liaison, Policy and Review, Division of NTP, NIEHS, P.O. Box 12233, K2–03, Research Triangle Park, NC 27709. Phone: 919– 541–9834, Fax: 919–541–0295, Email: whiteld@niehs.nih.gov. Hand Deliver/ Courier address: 530 Davis Drive, Room K2136, Morrisville, NC 27560. SUPPLEMENTARY INFORMATION: Preliminary Agenda and Other Meeting Information: A preliminary agenda, roster of SACATM members, background materials, public comments, and any additional information, when available, will be posted on the SUMMARY: PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 45253 SACATM meeting Web site (https:// ntp.niehs.nih.gov/go/32822) or available upon request from the Designated Federal Officer. Following the meeting, summary minutes will be prepared and available on the SACATM Web site or upon request. Meeting and Registration: This meeting is open to the public with time scheduled for oral public comments; attendance is limited only by the space available. Individuals who plan to attend and/or provide comments are encouraged to preregister online at the SACATM meeting Web site (https:// ntp.niehs.nih.gov/go/32822) by September 17, 2013, to facilitate planning for the meeting. Individuals interested in the meeting are encouraged to access this Web site to stay abreast of the most current information regarding the meeting. Visitor and security information for those attending in person is available at niehs.nih.gov/ about/visiting/index.cfm. Individuals with disabilities who need accommodation to participate in this event should contact Ms. Robbin Guy at phone: (919) 541–4363 or email: guyr2@niehs.nih.gov. TTY users should contact the Federal TTY Relay Service at 800–877–8339. Requests should be made at least five business days in advance of the event. Request for Comments: Both written and oral public inputs on the agenda topics are invited. Written comments received in response to this notice will be posted on the meeting Web site and persons submitting them will be identified by their name and affiliation and/or sponsoring organization, if applicable. Persons submitting written comments should include their name, affiliation (if applicable), and sponsoring organization (if any) with the document. Time is allotted during the meeting for presentation of oral comments and each organization is allowed one time slot per public comment period. At least 7 minutes will be allotted for each speaker, and if time permits, may be extended up to 10 minutes at the discretion of the chair. Registration for oral comments will also be available on-site, although time allowed for presentation by on-site registrants may be less than for preregistered speakers and will be determined by the number of persons who register at the meeting. In addition to in-person oral comments at the meeting, public comments can be presented by teleconference line. There will be 50 lines for this call; availability will be on a first-come, first-served basis. The lines will be open from 9:00 a.m. until approximately 4:30 p.m., although public comments will be E:\FR\FM\26JYN1.SGM 26JYN1 tkelley on DSK3SPTVN1PROD with NOTICES 45254 Federal Register / Vol. 78, No. 144 / Friday, July 26, 2013 / Notices received only during the formal public comment periods, which will be indicated on the preliminary agenda. The access number for the teleconference line will be provided to registrants by email prior to the meeting. Persons wishing to present oral comments are encouraged to pre-register on the SACATM meeting registration form (https://ntp.niehs.nih.gov/go/ 32822), indicate whether they will present comments in-person or via the teleconference line, indicate the topic(s) on which they plan to comment, and send a copy of their statement to Dr. White (whiteld@niehs.nih.gov) by September 17, to enable review by SACATM, NICEATM, ICCVAM, and NIEHS/NTP staff prior to the meeting. Written statements can supplement and may expand the oral presentation. If registering on-site and reading from written text, please bring 40 copies of the statement for distribution and to supplement the record. Background Information on ICCVAM, NICEATM, and SACATM: ICCVAM is an interagency committee composed of representatives from 15 Federal regulatory and research agencies that require, use, generate, or disseminate toxicological and safety testing information. ICCVAM conducts technical evaluations of new, revised, and alternative safety testing methods with regulatory applicability and promotes the scientific validation and regulatory acceptance of toxicological and safety-testing methods that more accurately assess the safety and hazards of chemicals and products and that reduce, refine (decrease or eliminate pain and distress), or replace animal use. The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l–3) established ICCVAM as a permanent interagency committee of the NIEHS under NICEATM. NICEATM administers ICCVAM, provides scientific and operational support for ICCVAM-related activities, and conducts independent validation studies to assess the usefulness and limitations of new, revised, and alternative test methods and strategies. NICEATM and ICCVAM work collaboratively to evaluate new and improved test methods and strategies applicable to the needs of U.S. Federal agencies. NICEATM and ICCVAM welcome the public nomination of new, revised, and alternative test methods and strategies for validation studies and technical evaluations. Additional information about ICCVAM and NICEATM can be found at https://iccvam.niehs.nih.gov. SACATM was established in response to the ICCVAM Authorization Act [Section 285l–3(d)] and is composed of VerDate Mar<15>2010 18:54 Jul 25, 2013 Jkt 229001 scientists from the public and private sectors. SACATM advises ICCVAM, NICEATM, and the Director of the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and activities of NICEATM. SACATM provides advice on priorities and activities related to the development, validation, scientific review, regulatory acceptance, implementation, and national and international harmonization of new, revised, and alternative toxicological test methods. Additional information about SACATM, including the charter, roster, and records of past meetings, can be found at https://ntp.niehs.nih.gov/go/167. Dated: July 17, 2013. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. 2013–17919 Filed 7–25–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; MSM Program Review. Date: October 11, 2013. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza 959, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Manana Sukhareva, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard Suite 959, Bethesda, MD 20892, 301–451–3397, sukharem@mail.nih.gov. PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 Dated: July 19, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–17918 Filed 7–25–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276– 1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Proposed Project: SAMHSA Tobacco Prevention, Cessation, and Behavioral Health Message Testing—NEW The Substance Abuse and Mental Health Services Administration (SAMHSA) is conducting message testing to inform the development and implementation of a tobacco use prevention and cessation campaign aimed at youth with substance use and/ or mental health conditions. The purpose of the project is to inform messaging efforts, through focus groups with youth and in-depth interviews with health care providers, to improve tobacco use prevention and cessation efforts in populations with mental health and substance use concerns, particularly youth and vulnerable populations. The focus groups and interviews are an integral E:\FR\FM\26JYN1.SGM 26JYN1

Agencies

[Federal Register Volume 78, Number 144 (Friday, July 26, 2013)]
[Notices]
[Pages 45253-45254]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-17919]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Toxicology Program Scientific Advisory Committee on 
Alternative Toxicological Methods; Announcement of Meeting; Request for 
Comments

SUMMARY: This notice announces a meeting of the Scientific Advisory 
Committee on Alternative Toxicological Methods (SACATM). SACATM advises 
the Interagency Coordinating Committee on the Validation of Alternative 
Methods (ICCVAM), the National Toxicology Program (NTP) Interagency 
Center for the Evaluation of Alternative Toxicological Methods 
(NICEATM), and the Director of the National Institute of Environmental 
Health Sciences (NIEHS) and NTP regarding statutorily mandated duties 
of ICCVAM and activities of NICEATM. Information about the meeting and 
registration are available at https://ntp.niehs.nih.gov/go/32822.

DATES: 
    Meeting: September 24, 2013, beginning at 9:00 a.m. Eastern 
Daylight Time and continuing until adjournment at approximately 4:30 
p.m.
    Written Public Comments Submissions: Deadline is September 10, 
2013.
    Pre-registration for Meeting and/or Oral Comments: Deadline is 
September 17, 2013.

ADDRESSES:
    Meeting Location: Rodbell Auditorium, Rall Building, NIEHS, 111 
T.W. Alexander Drive, Research Triangle Park, NC 27709.
    Meeting Web page: The preliminary agenda, registration, and other 
meeting materials are at https://ntp.niehs.nih.gov/go/32822. It is not 
necessary to preregister for the meeting to view the webcast.
    Webcast: A link to access the meeting webcast will be available on 
the meeting Web page.

FOR FURTHER INFORMATION CONTACT: Dr. Lori White, Designated Federal 
Officer for SACATM, Office of Liaison, Policy and Review, Division of 
NTP, NIEHS, P.O. Box 12233, K2-03, Research Triangle Park, NC 27709. 
Phone: 919-541-9834, Fax: 919-541-0295, Email: whiteld@niehs.nih.gov. 
Hand Deliver/Courier address: 530 Davis Drive, Room K2136, Morrisville, 
NC 27560.

SUPPLEMENTARY INFORMATION: 
    Preliminary Agenda and Other Meeting Information: A preliminary 
agenda, roster of SACATM members, background materials, public 
comments, and any additional information, when available, will be 
posted on the SACATM meeting Web site (https://ntp.niehs.nih.gov/go/32822) or available upon request from the Designated Federal Officer. 
Following the meeting, summary minutes will be prepared and available 
on the SACATM Web site or upon request.
    Meeting and Registration: This meeting is open to the public with 
time scheduled for oral public comments; attendance is limited only by 
the space available. Individuals who plan to attend and/or provide 
comments are encouraged to preregister online at the SACATM meeting Web 
site (https://ntp.niehs.nih.gov/go/32822) by September 17, 2013, to 
facilitate planning for the meeting. Individuals interested in the 
meeting are encouraged to access this Web site to stay abreast of the 
most current information regarding the meeting. Visitor and security 
information for those attending in person is available at 
niehs.nih.gov/about/visiting/index.cfm. Individuals with disabilities 
who need accommodation to participate in this event should contact Ms. 
Robbin Guy at phone: (919) 541-4363 or email: guyr2@niehs.nih.gov. TTY 
users should contact the Federal TTY Relay Service at 800-877-8339. 
Requests should be made at least five business days in advance of the 
event.
    Request for Comments: Both written and oral public inputs on the 
agenda topics are invited. Written comments received in response to 
this notice will be posted on the meeting Web site and persons 
submitting them will be identified by their name and affiliation and/or 
sponsoring organization, if applicable. Persons submitting written 
comments should include their name, affiliation (if applicable), and 
sponsoring organization (if any) with the document. Time is allotted 
during the meeting for presentation of oral comments and each 
organization is allowed one time slot per public comment period. At 
least 7 minutes will be allotted for each speaker, and if time permits, 
may be extended up to 10 minutes at the discretion of the chair. 
Registration for oral comments will also be available on-site, although 
time allowed for presentation by on-site registrants may be less than 
for pre-registered speakers and will be determined by the number of 
persons who register at the meeting. In addition to in-person oral 
comments at the meeting, public comments can be presented by 
teleconference line. There will be 50 lines for this call; availability 
will be on a first-come, first-served basis. The lines will be open 
from 9:00 a.m. until approximately 4:30 p.m., although public comments 
will be

[[Page 45254]]

received only during the formal public comment periods, which will be 
indicated on the preliminary agenda. The access number for the 
teleconference line will be provided to registrants by email prior to 
the meeting.
    Persons wishing to present oral comments are encouraged to pre-
register on the SACATM meeting registration form (https://ntp.niehs.nih.gov/go/32822), indicate whether they will present 
comments in-person or via the teleconference line, indicate the 
topic(s) on which they plan to comment, and send a copy of their 
statement to Dr. White (whiteld@niehs.nih.gov) by September 17, to 
enable review by SACATM, NICEATM, ICCVAM, and NIEHS/NTP staff prior to 
the meeting. Written statements can supplement and may expand the oral 
presentation. If registering on-site and reading from written text, 
please bring 40 copies of the statement for distribution and to 
supplement the record.
    Background Information on ICCVAM, NICEATM, and SACATM: ICCVAM is an 
interagency committee composed of representatives from 15 Federal 
regulatory and research agencies that require, use, generate, or 
disseminate toxicological and safety testing information. ICCVAM 
conducts technical evaluations of new, revised, and alternative safety 
testing methods with regulatory applicability and promotes the 
scientific validation and regulatory acceptance of toxicological and 
safety-testing methods that more accurately assess the safety and 
hazards of chemicals and products and that reduce, refine (decrease or 
eliminate pain and distress), or replace animal use. The ICCVAM 
Authorization Act of 2000 (42 U.S.C. 285l-3) established ICCVAM as a 
permanent interagency committee of the NIEHS under NICEATM. NICEATM 
administers ICCVAM, provides scientific and operational support for 
ICCVAM-related activities, and conducts independent validation studies 
to assess the usefulness and limitations of new, revised, and 
alternative test methods and strategies. NICEATM and ICCVAM work 
collaboratively to evaluate new and improved test methods and 
strategies applicable to the needs of U.S. Federal agencies. NICEATM 
and ICCVAM welcome the public nomination of new, revised, and 
alternative test methods and strategies for validation studies and 
technical evaluations. Additional information about ICCVAM and NICEATM 
can be found at https://iccvam.niehs.nih.gov.
    SACATM was established in response to the ICCVAM Authorization Act 
[Section 285l-3(d)] and is composed of scientists from the public and 
private sectors. SACATM advises ICCVAM, NICEATM, and the Director of 
the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and 
activities of NICEATM. SACATM provides advice on priorities and 
activities related to the development, validation, scientific review, 
regulatory acceptance, implementation, and national and international 
harmonization of new, revised, and alternative toxicological test 
methods. Additional information about SACATM, including the charter, 
roster, and records of past meetings, can be found at https://ntp.niehs.nih.gov/go/167.

    Dated: July 17, 2013.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2013-17919 Filed 7-25-13; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.